⌘K
Loading ticker…
iShares Genomics Immunology and Healthcare ETF · Other
3m RS is unavailable, Market Stance is 47.8
As of 2026-08-24, iShares Genomics Immunology and Healthcare ETF (IDNA) has a 3-month relative strength percentile of — within the TickerStance CS+ADRC universe (~5,000 tickers). The current market Stance is 47.8 (Neutral). Sector: Other. Average daily range 2.0%, relative volume 2.41×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
| # | Holding | Weight | Value |
|---|---|---|---|
| 1 | RVMD | 6.85% | $11M |
| 2 | MRNA | 6.28% | $10M |
| 3 | IPSEN SA | 5.24% | $8M |
| 4 | MRK | 4.15% | $7M |
| 5 | BNTX | 4.07% | $7M |
| 6 | EXEL | 3.80% | $6M |
| 7 | TWST | 3.79% | $6M |
| 8 | REGN | 3.73% | $6M |
| 9 | VRTX | 3.55% | $6M |
| 10 | INCY | 3.52% | $6M |
| 11 | IDYA | 2.71% | $4M |
| 12 | IBRX | 2.61% | $4M |
| 13 | CAI | 2.44% | $4M |
| 14 | RCUS | 2.12% | $3M |
| 15 | CRSP | 1.80% | $3M |
| 16 | NVAX | 1.31% | $2M |
| 17 | IOVA | 1.24% | $2M |
| 18 | GenFleet Therapeutics (Shanghai) Inc | 1.20% | $2M |
| 19 | NUVB | 1.18% | $2M |
| 20 | VIR | 1.07% | $2M |
| 21 | ABCL | 1.06% | $2M |
| 22 | CRVS | 0.97% | $2M |
| 23 | JANX | 0.86% | $1M |
| 24 | KURA | 0.83% | $1M |
| 25 | Sunshine Lake Pharma Co Ltd | 0.62% | $1M |
Showing 25 of 43 holdings.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
Daily range, ATR, beta, and the math for a 1-ADR stop.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | IDNA Jan avg: 3.38% median: 3.89% win: 75% σ: 5.56% n: 4 2022-04-12 → 2026-07-31 | IDNA Feb avg: 1.47% median: 3.65% win: 50% σ: 9.39% n: 4 2022-04-12 → 2026-07-31 | IDNA Mar avg: -4.88% median: -5.02% win: 0% σ: 3.69% n: 4 2022-04-12 → 2026-07-31 | IDNA Apr avg: -2.72% median: 0.73% win: 60% σ: 6.15% n: 5 2022-04-12 → 2026-07-31 | IDNA May avg: 0.19% median: 1.67% win: 60% σ: 3.79% n: 5 2022-04-12 → 2026-07-31 | IDNA Jun avg: 2.12% median: 0.80% win: 60% σ: 6.29% n: 5 2022-04-12 → 2026-07-31 | IDNA Jul avg: 3.78% median: 3.61% win: 80% σ: 5.26% n: 5 2022-04-12 → 2026-07-31 | IDNA Aug avg: -1.88% median: -2.77% win: 50% σ: 5.23% n: 4 2022-04-12 → 2026-07-31 (current) | IDNA Sep avg: -3.86% median: -5.47% win: 25% σ: 8.15% n: 4 2022-04-12 → 2026-07-31 | IDNA Oct avg: -0.57% median: 0.65% win: 50% σ: 7.91% n: 4 2022-04-12 → 2026-07-31 | IDNA Nov avg: 7.05% median: 5.96% win: 100% σ: 5.30% n: 4 2022-04-12 → 2026-07-31 | IDNA Dec avg: -3.10% median: -6.70% win: 25% σ: 10.03% n: 4 2022-04-12 → 2026-07-31 |
Holdings of IDNA currently on TickerStance stock-RS leaderboards.
Metrics matched 35 tickers across 43 holdings rows (65.2% of fund weight). Metrics as of 2026-08-24; holdings from the filing.